PolarCool

Med-tech company PolarCool AB (publ) has further expanded the reach of PolarCap® in European ice hockey. The company has recently finalized a two-year commercial agreement with Rungsted Seier Capital, a prominent Danish club.

PolarCool develops and markets the PolarCap® System, a product that alleviates the effects of concussion injuries. PolarCap® is primarily used by sports organizations and facilities in contact sports such as ice hockey, rugby, football, and handball, as well as in sports with an increased risk of concussion.

Rungsted Seier Capital, a competitive team playing in the Metal Ligaen, joins Sønderjyske as the second team to adopt PolarCap for enhanced concussion management. This milestone achievement solidifies the inclusion of PolarCap® across professional teams from all Nordic first leagues. While the financial impact of individual agreements may be limited, this strategic partnership holds immense importance for PolarCool's continued establishment in the Metal Ligaen.

Rungsted Seier Capital CEO, Thomas Friberg comments;

-Prioritizing the health of our players is a priority for us in Rungsted. It is gratifying that we now will be able to provide improved treatment to our players when suffering a concussion.

PolarCool's CEO, Erik Andersson comments;

-By securing the agreement with Rungsted Seier Capital, we continue to establish PolarCap as a cutting-edge medical technology to treat concussion. The adoption by yet another top club demonstrates the growing recognition of its effectiveness and clinical effect.

-We are now in an intense period market-wise as ice hockey and rugby clubs prepare for the upcoming season. We look forward to continued success in these segments in Europe.